Treace Medical Concepts (TMCI) Invested Capital (2020 - 2026)

Treace Medical Concepts (TMCI) has 7 years of Invested Capital data on file, last reported at $79.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 25.07% year-over-year to $79.0 million; the trailing twelve-month figure through Mar 2026 stood at $79.0 million (down 25.07% YoY), and the FY2025 full-year result was $89.1 million, down 21.1% from the prior year.
• Invested Capital for Q1 2026 stood at $79.0 million, down from $89.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $157.6 million in Q1 2023 and bottomed at $60.5 million in Q4 2022.
• The 5-year median for Invested Capital is $104.9 million (2024), against an average of $104.9 million.
• Peak annual rise in Invested Capital reached 204.1% in 2022, while the deepest fall reached 36.12% in 2022.
• A 5-year view of Invested Capital shows it stood at $60.5 million in 2022, then soared by 127.89% to $137.9 million in 2023, then retreated by 18.16% to $112.9 million in 2024, then slipped by 21.1% to $89.1 million in 2025, then decreased by 11.35% to $79.0 million in 2026.
• The last three Invested Capital figures came in at $79.0 million (Q1 2026), $89.1 million (Q4 2025), and $91.0 million (Q3 2025), per Business Quant data.

Peer Comparison